Atossa Advances (Z)-Endoxifen With FDA-Backed Strategy to Accelerate Breast Cancer Development Pathways
Seattle, WA — December 4, 2025 Atossa Therapeutics has outlined an accelerated FDA regulatory strategy to advance its investigational therapy,...
Clinical
Advertisement
FDA Grants Orphan Drug Designation to J&D’s HCC Therapy, Accelerating New Options for Liver Cancer Treatment
Monmouth, NJ — December 4, 2025 J & D Pharmaceuticals LLC has received U.S. FDA Orphan Drug Designation for its...
FDA Clears Advanced Omnipod 5 Algorithm, Accelerating Next-Generation Insulin Automation
Insulet Corporation has secured FDA 510(k) clearance for a suite of algorithm enhancements to its Omnipod® 5 Automated Insulin...
TAEUS Liver Shows MRI-Level Accuracy, Advancing MASLD/MASH Trials
ANN ARBOR, Mich. – December 4, 2025 — ENDRA Life Sciences has released compelling new feasibility data showing that...
Advertisement
